<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Twice-yearly depemokimab demonstrates sustained asthma exacerbation reduction over 2 years

Default sub title

minute read

by Healio | March 20, 2026
placeholder

Topics: Press Coverage